<DOC>
	<DOCNO>NCT02113787</DOCNO>
	<brief_summary>The purpose study prove bioequivalence brand generic topiramate .</brief_summary>
	<brief_title>Switchability Study Between Brand Generic Topiramate</brief_title>
	<detailed_description>Generic antiepileptic drug ( AED ) achieve blood concentration similar brand AED . However , controversy exist efficacy safety substitute generic AEDs . Because even minor absorption kinetic difference elicit breakthrough seizure patient change generic AED brand AED . Therefore , ideal evaluation interchangeability brand AEDs generic formulation drug three-way four-way crossover study , evaluate within-subject variability pharmacokinetic pharmacodynamic . Investigator design four-way crossover study aim assess bioequivalence brand generic topiramate , measure trough serum level , evaluate efficacy , tolerability side effect generic topiramate .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>age 1865 year Patients epilepsy take topamax 100mg bid need take topamax 100mg bid poor compliance subject whose dose antiepileptic drug change study subject whose seizure wellcontrolled judged neurologist history kind drug allergy pregnancy nursing exist recent significant disease ( cardiac , hepatic , renal disease , severe diabetes mellitus , sepsis , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>anticonvulsant</keyword>
	<keyword>generic drug</keyword>
</DOC>